ABSTRACT. A 4-year-old female Siberian Husky was diagnosed with pyogranulomatous steatitis at the site of a recurrence of left anal sac rupture (day 1). Carprofen and orbifloxacin were given for 13 days without improvement. A single dose of meloxicam was administered prior to surgical resection of the anal sac, and based on elevated liver enzyme activity, liver supportive therapy was initiated. The dog received carprofen and orbifloxacin orally on the evening of day 14. The dog became anorectic the following morning, and began vomiting. Despite supportive therapy, the dog was unresponsive to treatment and died on day 16. Postmortem examination revealed severe vacuolar change and acute necrosis of hepatocytes consistent with carprofen and meloxicam induced-toxicosis. KEY WORDS: canine, drug-intoxication, NSAIDs.J. Vet. Med. Sci. 67(10): 1051-1053, 2005 Appropriate pain management is essential to improving patient quality of life. Non-steroidal anti-inflammatory drugs (NSAIDs) relieve pain by reducing prostaglandin (PG) synthesis via inhibition of cyclooxygenase (COX) production. Carprofen and meloxicam preferentially inhibit COX-2, which promotes production of PG, a mediator of inflammation [2,5,7]. Prolonged oral administration of carprofen or meloxicam in dogs is rarely associated with the development of adverse reactions; however, when reactions do occur, vomiting, diarrhea, and anorexia have been emphasized [3,6,9,11]. In addition, carprofen-induced hepatotoxicity has also been reported as an occasional adverse reaction, with some cases of canine fatality reported [10,12]. However, there have been no reports of hepatotoxicity caused by alternate administration of carprofen and meloxicam. The present paper describes the case of a Siberian Husky that died of acute hepatocellular necrosis associated with alternate administration of carprofen and meloxicam.A 4-year-old intact female Siberian Husky weighing 27.8 kg was presented with the chief complaint of anorexia and rupture of a mass located on the left ventral side of the anus. The patient had experienced the same problem twice in the past year. For the first event, the patient was given carprofen (4 mg/kg sid PO) and orbifloxacin (5 mg/kg sid PO) for 24 days. Complete blood count (CBC) and blood chemical analysis 17 days after initiation of medication revealed increases in alanine aminotransferase (ALT: 410 U/l; reference range: 10 to 118 U/l) and aspartate aminotransferase (AST: 316 U/l; reference range: 12 to 43 U/l) activities. Glutathione, ursodeoxycholic acid, and taurine were subsequently given orally for 1 week. Three months after cessation of carprofen and orbifloxacin administration, ALT activity had decreased to 38.3 U/l. For the second event, the patient was given the same medication for 1 week, and blood analysis was not performed. However, the dog did not show any clinical signs of adverse reaction to the medications. The dog had been inoculated with an eight-in-one combination vaccine containing antigens of Leptospira canicola, L. copenhageni, L...